RKLBSPCE·Apr 13, 2026·5 min read

SpaceX $1.75T IPO Buzz: RKLB at 63x Sales Looks Reasonable — SPCE Does Not

SpaceX's $1.75T IPO speculation and Starlink praise highlight valuation gaps: RKLB's 63x EV/Sales reflects 38% growth but risks SpaceX competition, while SPCE's 135x on -78% revenue collapse looks untenable. RKLB merits ownership over SPCE, though both pale against the private benchmark.

With SpaceX's $1.75T IPO Buzz and Starlink Praise from Marc Andreessen, Do RKLB or SPCE Deserve Comparable Valuation Premiums?

Financial outlets this week published analysis on SpaceX's planned initial public offering, highlighting expectations of a $1.75 trillion valuation fueled by its dominant rocket launch business and Starlink's breakout performance. Investor Marc Andreessen lauded Starlink as an "underappreciated tech success," underscoring the private giant's edge just as public space peers Rocket Lab (RKLB) and Virgin Galactic (SPCE) grapple with sky-high multiples. This SpaceX hype train raises a critical question: Are RKLB and SPCE's valuations justified, or are they absurdly inflated against the private benchmark?

Valuation Multiples: Public Peers Dwarfed by SpaceX's Scale

SpaceX's rumored $1.75 trillion valuation implies an enterprise value-to-sales multiple north of 20x on estimated $10B+ annual revenue (driven by ~$7B from Starlink subscriptions and $4B+ from launches). In contrast, public space stocks command even loftier premiums despite minuscule scale and profitability hurdles.

MetricRKLBSPCESpaceX (Est.)
Market Cap$38.7B$191M$1.75T
EV/Sales TTM63.1x134.7x~20x
P/S TTM60.4x123.6xN/A
Debt/Equity0.15x1.18xLow (Est.)
Price$68.05$3.02N/A

RKLB's $38B market cap reflects optimism around its Neutron rocket development and 38% TTM revenue growth to ~$436M in FY2024 (ending Dec 2024). Yet at 63x EV/Sales, it's pricing in flawless execution against SpaceX's Falcon 9 monopoly. SPCE, focused on suborbital tourism, trades at an indefensible 135x EV/Sales amid -78% TTM revenue contraction—its $208M EV barely covers ongoing cash burn.

Rocket Lab's filings explicitly name SpaceX as a top competitor in rideshare and dedicated launches, citing factors like flight heritage and pricing. Virgin Galactic acknowledges SpaceX's orbital focus but warns of potential shifts into suborbital, while Blue Origin pauses tourism flights.

Revenue Growth and Path to Profitability: RKLB Pulling Away

RKLB demonstrates real traction: Revenue surged from $211M in FY2022 to $436M in FY2024, with Q4 2024 at $132M and FY2025 guidance implying $602M (period ending Dec 2025). Gross profit climbed to $116M in FY2024, though operating losses persist at -$190M due to Neutron R&D. Free cash flow remains negative (-$116M FY2024), but cash reserves swelled to $828M by Q4 2025, buffering $254M debt.

SPCE lacks comparable momentum. TTM revenue growth cratered -78%, with EBITDA growth at just 21% masking deeper woes—no recent financial statements available, but snapshot metrics signal collapse. Its space tourism model faces scalability limits, with tickets once priced at $450K but flights infrequent post-delays.

Period (Latest FY)RKLB RevenueRKLB Growth YoYSPCE Revenue Growth TTMSpaceX Est. Revenue
FY2024 (Dec 2024)$436M+78%-78%~$10B
FY2025 Proj (Dec 2025)$602M+38%N/A$15B+ (Est.)
Gross Profit (Latest)$116M (2024)N/AN/AMulti-Billion
Net Income (Latest)-$190MImprovingDeep LossesProfitable (Est.)

RKLB ranks #1 among publics for growth, with Electron launches (60+ to date) and space systems contributing. SPCE ranks dead last, its tourism niche overshadowed by Starlink's 5M+ users (e.g., Kyivstar integration) and SpaceX's Transporter missions carrying rivals like Spire Global.

Note: RKLB and SPCE follow calendar fiscal years, aligning periods directly. SpaceX estimates from analyst consensus and news.

Structural Moats: SpaceX's Unmatched Dominance

SpaceX controls 60%+ of global launches, with reusable Falcon 9 slashing costs 10x vs. expendable rivals. Starlink's 7,000+ satellites generate recurring high-margin revenue, praised by Andreessen as a Tesla-like disruptor. RKLB's medium-lift Neutron (2025 debut) targets a niche, but SEC filings stress competition risks from SpaceX's scale. SPCE's Delta-class ships aim for weekly flights, yet safety pauses and high costs hinder.

RKLB edges SPCE on execution: Q3 2025 revenue hit $155M (+48% YoY), with equity at $1.7B vs. SPCE's erosion. Both burn cash—RKLB's -$322M FCF FY2025—but RKLB's lower leverage (net debt/EBITDA 3.4x) signals resilience.

Recent news amplifies the gap: SpaceX's Transporter-16 launched 100+ satellites (including WISeKey's), while XOVR ETF pitches pre-IPO exposure at $1.75T. Publics like RKLB benefit indirectly but can't match.

Who to Own: RKLB Over SPCE, But Fade the Hype

Own RKLB conditionally: At 60x sales, it's the growth leader (#1 rank) with Neutron as a catalyst. Revenue trajectory mirrors early SpaceX, and $828M cash funds the race. Target: $80+ if Q1 2026 beats.

Avoid SPCE: 135x EV/Sales on collapsing revenue (#3 rank) screams value trap. Tourism remains a gimmick vs. launches/Starlink.

Benchmark Verdict: Neither justifies SpaceX-like premiums. RKLB trades at 3x its EV vs. SpaceX's scale-adjusted 20x—overvalued but less absurd. SPCE? Absurdly so.

Valuation check: RKLB's PEG implies froth; SPCE's negative earnings void P/E. Both lag SpaceX's profitability moat.

Catalysts to Watch

  • RKLB: Neutron first launch (H2 2025), Q1 2026 earnings (May 2026).
  • SPCE: Delta flights resume? Unlikely near-term.
  • SpaceX: IPO filing could crush sentiment if valuations compress publics.

As Starlink scales, public space stocks must prove they're not just riding SpaceX's coattails. RKLB shows promise; SPCE does not.

Want deeper analysis?

Ask drillr anything about RKLB, SPCE -- powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free